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Abstract
In the context of precision medicine, understanding patient-specific variation is an important step
in developing targeted and patient-tailored treatment regimens for periodontitis. While several
studies have successfully demonstrated the usefulness of molecular expression profiling in
conjunction with single classifier systems in discerning distinct disease groups, the majority of
these studies do not provide sufficient insights into potential variations within the disease groups.
Aim—The goal of the present study is to discern biological response profiles of periodontitis and
non-periodontitis smoking subjects using an informed panel of biomarkers across multiple scales
(salivary, oral microbiome, pathogens and other markers).
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Materials and Methods—The investigation uses a novel ensemble classification approach
(SVA-SVM) to differentiate disease groups and patient-specific biological variation of systemic
inflammatory mediators and IgG antibody to oral commensal and pathogenic bacteria within the
groups.
Results—Sensitivity of SVA-SVM is shown to be considerably higher than several traditional
independent classifier systems. Patient-specific networks generated from SVA-SVM are also
shown to reveal cross-talk between biomarkers in discerning the disease groups. High-confidence
classifiers in these network abstractions comprised of host responses to microbial infection
elucidated their critical role in discerning the disease groups.
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Conclusions—Host adaptive immune responses to the oral colonization/infection contribute
significantly to creating the profiles specific for periodontitis patients with potential to assist in
defining patient-specific risk profiles and tailored interventions.
Keywords
periodontitis; smoking; saliva; serum; oral bacteria
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Introduction
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Periodontitis is a chronic destructive inflammatory disease that affects a majority of U.S. and
global adults (Jin et al., 2011, Eke et al., 2012, Baelum and Lopez, 2013, Eke et al., 2015)
and has been associated with significant systemic consequences for general health (Linden et
al., 2013, Torumtay et al., 2015, Hajishengallis, 2015, Kumar, 2016). While clinical
parameters are used in dental practice to identify disease, several critical limitations in
addressing 21st century dentistry exist by constraining diagnostic and prognostic decisions
based upon these clinical parameters. A principal issue with the clinical measures is that a
significant amount of damage must occur before these diagnostic parameters are able to
detect a sufficient level of disease, and are distanced in time from the biologic processes that
initiated the disease progression. These clinical parameters, as currently obtained, cannot
determine the current status of disease progression, nor effectively predict the rapidity and
timing of exacerbation and progression, as well as the likely response to therapeutic
intervention. Therefore, identifying signatures of biologic responses that occur early in the
kinetics of the disease, presage disease progression, and provide guidance on treatment
decisions and more rapid evaluation of treatment success would be of significant value to the
field (Armitage, 2013, Slots, 2013, Matthews, 2014).

Author Manuscript
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Disease phenotypes are often preceded by marked changes in the activity of several variables
(molecular, microbial and others) across multiple scales. Understanding these changes can
be especially helpful in identifying potential biomarkers with the capability to discern
disease groups. Recent studies, with complex disease phenotypes, have clearly demonstrated
the usefulness of single classifiers in conjunction with molecular profiling in discerning
distinct disease groups (Kebschull and Papapanou, 2010, Kebschull et al., 2013). While
useful, molecular profiling interrogates the groups of interest only at a single scale and
traditional single classifiers do not provide sufficient insights into potential patient-specific
variations within the disease groups of interest in their native or “out-of-the box” form.
Understanding such variations is especially critical in developing patient-tailored treatment
strategies. As importantly, the literature is replete with publications demonstrating
differences in host factors (Eren et al., 2015, Winning et al., 2015, Lutfioglu et al., 2016) and
oral microbes (Shchipkova et al., 2010, Bizzarro et al., 2013) in smokers compared to nonsmokers. However, it is important to recognize disease variation within the smoking
population, and thus critical to delineate the unique biological features of health and disease
in the smoking population (Haytural et al., 2015, Eren et al., 2015). The present study,
applies an ensemble classification framework (SVA: selective voting ensemble classification
approach) (Nagarajan et al., 2015b, Nagarajan and Upreti, 2016) for discerning the biology
of periodontitis and non-periodontitis populations, while providing insights into potential
variations within the periodontitis population. In a recent study (Nagarajan et al., 2015b), we
had demonstrated the usefulness of SVA in understanding potential variations between
gingivitis and periodontitis populations using four critical salivary biomarkers (IL-1β, IL-6,
MIP-1α, MMP-8) corresponding to fundamental biologic processes driving the disease such
as inflammation, tissue destruction, and bone remodeling (Ebersole et al., 2013a,
Hajishengallis and Sahingur, 2014, Reynolds, 2014, Silva et al., 2015, Hienz et al., 2015).
Unlike traditional single classifiers, SVA is an ensemble approach and varies the feature sets
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in a sample-specific manner using a majority voting strategy revealing potential samplespecific variations within and between the disease groups of interest. In contrast to
traditional disease classification based on molecular expression profiling, the present study
discerns periodontitis and periodontitis and non-periodontitis subjects using an integrated set
of biomarkers. These informed set of biomarkers interrogate the disease groups at multiple
scales and comprise of molecular markers, microbial markers (pathogenic, commensal
bacteria), and other markers. Such an integrated approach also has the ability to reveal
potential cross-talk (Nagarajan et al., 2016b) between the biomarkers across distinct scales
in contrast to traditional classification using molecular expression profiles. Performance of
SVA (sensitivity, specificity, accuracy) is also compared to those obtained using five
different single classifier approaches (Linear Discriminant Analysis (LDA); Quadratic
Discriminant Analysis (QDA); Support Vector Machine (SVM); Naïve Bayes (NB) and
Classification and Regression Tree (CART)).

Author Manuscript
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Traditional single classifiers, while helpful, use all the biomarkers simultaneously as features
in the classification process resulting in a sparse representation of the samples in a highdimensional space with dimensions of the classifier often comparable to that of the sample
size. In contrast, SVA uses pairs of variables for each classifier and pools the results across
these ensemble of classifiers using a voting strategy (e.g. majority voting) (Kuncheva, 2004).
Normalized vote-counts and differential proclivity estimates from SVA is shown to vary
considerably within the periodontitis samples with a subset of borderline cases with equal
proclivity to periodontitis and non-periodontitis. The ensemble sets of these borderline cases
also exhibited lack of overlap with the rest of the periodontitis samples. Patient-specific
network abstractions of the ensemble sets revealed markedly differently topology between
samples with varying proclivities. High-confidence classifiers in these networks comprised
primarily of microbial biomarkers revealing their usefulness in capturing patient-specific
variations within the periodontitis group.

Methods and Materials
Patient Population and Clinical Parameters

Author Manuscript

The study population consisted of (N=117) non-periodontitis subjects (58 periodontally
healthy subjects; 59 gingivitis patients; 77.2% female) from ages 21–65 and (N=117)
periodontitis patients with ages 22–59 years (55.2% female) who were all smokers. The
protocol for this study was approved by the University of Kentucky Institutional Review
Board and all participants signed an appropriate consent form. A comprehensive oral and
periodontal examination was completed to assess the periodontal health. Inclusion/exclusion
criteria for participating in the study: must be smokers, able to complete a questionnaire and
sign a consent form, have a minimum of 20 teeth, willing to have blood drawn, whole saliva
collected, and have a full periodontal evaluation. The clinical evaluation of the periodontium
included mean probing pocket depth (PPD), clinical attachment level, and bleeding on
probing (BOP) as we have described previously (Novak et al., 2008, Ebersole et al., 2009,
Miller et al., 2014, Nagarajan et al., 2015a). Measures of BOP and PPD were used to
categorize the patients: mean PPD ≤2.5 mm for non-periodontitis (ie. Health and Gingivitis)
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and ≥2.5 mm for periodontitis. Variables such as age (Age), pack years of smoking (Yrs),
and salivary cotinine (Cot) levels were also included in the analysis.
Serum Analyses

Author Manuscript

Serum from a venipuncture blood sample was evaluated from 234 subjects (nonperiodontitis smokers, NP, N=117; periodontitis smokers, PD, N=117) groups. An analysis
determined antibody levels to a group of oral bacteria: Aggregatibacter
actinomycetemcomitans (Aa) strain JP2, Porphyromonas gingivalis (Pg) ATCC 33277,
Treponema denticola (Td) ATCC 35405, Streptococcus sanguinis (Ss) ATCC 10556,
Actinomyces naeslundii (An) ATCC 49340, Veillonella parvula (Vp) ATCC 10790,
Capnocytophaga ochracea (Co) ATCC 33596. An ELISA was used to determine the level of
IgG antibody to the bacteria (Ebersole et al., 2008). Serum inflammatory markers, included
interleukin-1β (IL-1β), plasminogen activator inhibitor-1 (PAI-1), myeloperoxidase (MPO),
interleukin (IL)-10, prostaglandin E2 (PGE2) and cotinine were evaluated as described
previously (Ebersole et al., 2002, Hayman et al., 2011, Ebersole et al., 2014, Nagarajan et
al., 2016a).
Statistical Analyses

Author Manuscript

The samples (N = 234) from periodontitis (N = 117) and non-periodontitis (N = 117)
smoking population were divided into training and test sets. The classifier was trained on the
training set (N = 200) comprising of 100 periodontitis and 100 non-periodontitis samples.
Subsequently, its performance was tested on an independent validation cohort (N = 34) or
test set comprising of 17 periodontitis and 17 non-periodontitis samples. Biomarkers (N =
13) used in the classification comprised of (a) molecular markers (4 markers, PGE2, IL1β,
MPO, PAI), (b) periodontal pathogens (3 pathogens, Aa, Pg, Td), (c) oral commensal
bacteria (4 bacteria, Ss, An, Vp, Co) and other variables (2 additional variables, Cotinine
levels, Years of Smoking). SVA using Support Vector Machines (SVM) as base classifier
using pairs of features for each of the base classifiers was used for classification and shall be
referred to as SVA-SVM in the following sections. Performance of SVA-SVM was also
compared to those obtained using traditional single classifier systems (LDA, QDA, NB,
CART, SVM).
Selective-Voting Ensemble Classification Approach (SVA)

Author Manuscript

The SVA implementation (Nagarajan and Upreti, 2016) consisted of two main parts working
in tandem. The first part determined the optimal sensitivity threshold from the training
samples and base classifiers that maximize the overall sensitivity of the ensemble.
Subsequently, this optimal sensitivity threshold was used in predicting class membership of
an independent validation cohort in the second part. Working principle of SVA and
comparison to traditional single classifier systems in discerning the profiles of periodontitis
and non-periodontitis groups is elucidated with a simple example in Figure 1 for
convenience. A more detailed explanation can be found elsewhere (Nagarajan and Upreti,
2016). The example considers four training samples (TR1, TR2, TR3, TR4). While (TR1,
TR2) were chosen to be non-periodontitis samples, (TR3, TR4) were chosen to be
periodontitis samples. The two test samples (TS1, TS2) considered were chosen as
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periodontitis samples. As noted earlier, SVA uses pairs of biomarkers (Figure 1b) as features
generating an ensemble of classifiers as opposed to traditional single classifiers that uses all
the biomarkers simultaneously in the classification process (Figure 1a). The four biomarkers
considered in the example, Figure 1, comprised of salivary markers (S1, S2) and microbial
markers (M1, M2), resulting in 4C2 = 6 potential classifiers {C12,C13,C14,C23,C24,C34} with
feature sets {S1S2, S1M1, S1M2, S2M1, S2M2, M1M2} respectively. Imposing the optimal
sensitivity threshold resulted in a subset of classifiers {C12, C13, C14, C23}. The ensemble
sets of the test sample TS1 are given by φ (TS1) = {C14} and ψ (TS1) = {C12, C13, C23}
whereas those of TS2 are given by φ (TS2) = {C23} and ψ (TS2) = {C12, C13, C14}. It is
important to note that for each of the test samples 3 out of 4 classifiers voted them as
periodontitis whereas 1 out of 4 voted them as non-periodontitis. Therefore, their normalized

Author Manuscript

,
vote counts based on majority voting is identical and given by
indicating equal proclivity of these test samples to the periodontitis as opposed to the nonperiodontitis group with (i. e. Δvotes=ψvotes − φvotes = 1/2 > 0).. While the results based on
normalized vote-counts from SVA correctly revealed equal proclivity of the test samples
TS1 and TS2 to periodontitis, network abstractions of their ensemble sets ψ (TS1)and ψ
(TS2) were markedly different, Figure 1. For instance, since ψ (TS1) = {C12, C13, C23}, the
corresponding features of the base classifiers are (M1M2, M1M3, M2M3) resulting in a
network with three nodes (M1, M2, M3) and three edges corresponding (M1-M2, M1-M3,
M2-M3). More importantly, these patient-specific networks not only reveal potential
variations within the periodontitis group but also cross-talk between salivary and microbial
biomarkers in this example.

Results
Author Manuscript

Optimal sensitivity threshold of SVA-SVM from the training sample

Author Manuscript

The optimal sensitivity threshold estimated on the training samples (N=200) using SVASVM is shown in Figure 2. Of interest is to note that the sensitivity of the ensemble (Figure
2, solid line) exhibits an increasing trend with the sensitivity threshold of the base classifiers
δ. The increasing trend of the ensemble sensitivity is also accompanied by a decreasing
trend in the ensemble specificity (Figure 2, dotted line) with the ensemble accuracy
remaining more or less constant around 0.7 (Figure 2, dashed line). The increase in the
overall sensitivity of the ensemble is especially pronounced when δ ≥ 0.5 with δ = 0.5
representing the case where only base classifiers that classify at least 50% of the
periodontitis samples correctly are members of the ensemble. The sensitivity of the
ensemble peaked around δ = 0.8. Any further increase in δ resulted in very few base
classifiers preventing reliable estimation of the ensemble performance. Since the primary
objective of the present study and biomarker development in general is increased sensitivity,
the optimal sensitivity threshold for selection of the base classifiers was set at δ = 0.8 for
SVA-SVM.
Performance of SVA-SVM on an independent validation cohort (test sample)
Performance of traditional single classifiers (LDA, QDA, NB, CART, SVM) and SVA-SVM
with δ = 0.5 and δ = 0.8 on the independent validation cohort comprising of (N = 34
samples; 17 Periodontitis, 17 Non-Periodontitis) is shown in Table 1. Mean performance
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measures (sensitivity, specificity, accuracy) along with their standard deviation estimated
from (N = 100) realizations for each of the classification techniques is shown in Table 1.
Among the single classifiers SVM had the highest average sensitivity (~60%) whereas Naïve
Bayes had the highest average specificity (~70%). The average accuracies of the single
classifiers were comparable with no apparent differences. However, SVA-SVM had
markedly higher average sensitivity ~70% for δ = 0.5 and ~85% for δ = 0.8 higher than all
the single classifiers. The average accuracy of SVA-SVM was also comparable to that of the
single classifiers.
Patient-specific variations in the periodontitis test samples

Author Manuscript

As noted earlier, unlike traditional single classifiers SVA-SVM can reveal patient-specific
variations within disease groups while discerning the disease groups by adapting the feature
sets in a patient-specific manner. Such variations are reflected in the normalized vote-counts,
hence the differential proclivity estimates of the samples. Differential proclivity estimates,
Figure 3 revealed considerable variation within the periodontitis test samples (N = 17) with a
subset of borderline samples exhibiting equal proclivity (Δ ~ 0) to periodontitis and nonperiodontitis groups. Three representative samples (6, 14, 9) with markedly proclivities were
identified from Figure 3. Samples 6 and 14 had similar proclivities (Δ ~ 0.75) markedly
different from that of the borderline sample 9(Δ ~ 0). Ensemble sets of the borderline
samples also failed to exhibit considerable overlap with the rest of the periodontitis test
samples and accompanied by characteristic dark streaks in the heatmap representation of the
consensus map (Nagarajan and Upreti, 2016), Figure 3.

Author Manuscript
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Patient-specific network (PSN) abstraction of the ensemble sets were subsequently
generated with the nodes representing the features or biomarkers and edges representing the
classifiers in the ensemble sets. The thickness of the edges correspond to the classifier
confidence across (N = 100) independent realizations. PSN of the three representative
periodontitis test samples (6, 14, 9) is shown in Figure 4. Unlike differential proclivity,
Figure 3, PSN revealed critical nodes, their interactions and variation in the overall topology
with considerable similarity between (6, 14) in contrast to that of sample 9. From Figure 4,
11 out of the 13 variables were retained in the PSNs of samples 6 and 14 whereas only 6
were retained in the PSN of sample 9. Unlike PSNs of samples 6 and 14, those of sample 9
were fragmented. High-confidence edges across samples 6 and 14 primarily comprised of
periodontal pathogens (Aa, Pg, Td) and their concerted working with oral commensal
bacteria (An, Ss) and molecular marker (PGE2), Figures 4a–4b. High-confidence edges
representing base classifiers with >40% confidence common to samples (6, 14) were
composed of pathogenic bacteria (Aa-Pg; Aa-Td), commensal bacteria (Aa-Ss; Aa-Co; AnCo) and their interaction (Aa-An; Td-Co; Td-An). The other prominent edges common to
samples 6 and 14 also consisted of interaction between the microbiome and molecular
entities with PGE2 playing a critical role (PGE2-Aa; PGE2-Td; PGE2-Ss; PGE2-An; PGE2Co). In contrast, many of these high-confidence edges were absent in the PSN corresponding
to sample 9, Figure 4c. However, a subset of the high-confidence classifiers (PGE2-Ss; AaCotn) was present consistently across these three representative samples. While the edge TdAn was also present in sample 9, its confidence barely passed the cut-off (40%). Ranking the
classifier confidence across the 17 periodontitis test samples also revealed that biomarkers
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(Aa-An and Aa-Ss) to be highly ranked classifiers (top two) across a majority of these
samples. These results essentially elucidate the critical role of pathogenic and commensal
bacteria and their concerted effort with other biomarkers in discerning periodontitis and nonperiodontitis smoking subjects while revealing patient-specific variations within the
periodontitis group. Interaction between the microbiome and molecular markers may also
provide novel insights into variations in the underlying molecular mechanisms due to
microbial challenge across these subjects.

Discussion

Author Manuscript
Author Manuscript

Since periodontitis represents a persistent inflammatory response to chronic biofilms
inhabiting the subgingival crevice (Hajishengallis, 2014, Nibali et al., 2014) the current
disease paradigm engages a model of variations in the quantity and quality of the oral
microbiome with disease. These microbial changes generate a dysregulated inflammatory
response or are in response to this dysregulated response, resulting in a microbial dysbiosis
that exacerbates the tissue destructive processes (Hajishengallis et al., 2012, Lamont and
Hajishengallis, 2015). Thus, measures of this disruption of biologic homeostasis can be
detected in the oral cavity and systemically, and biomolecules representing the various
stages of progression of the infection and destructive inflammatory response evaluated
(Ebersole et al., 2013b, Lappin et al., 2013, Salazar et al., 2013, Salminen et al., 2014,
Gumus et al., 2014, Saraiva et al., 2014, Longo et al., 2014, Ebersole et al., 2015, Torumtay
et al., 2015). Also to be noted in examining host responses in periodontitis is the clear role
of adaptive immunity, and particularly humoral immune responses in the development of, or
protection from, periodontitis (Ebersole et al., 2001, Ebersole et al., 2013a). It is well
documented that the host responds to oral bacteria with generally elevated levels of antibody
to putative oral pathogens in both serum and gingival crevicular fluid in disease; however,
some reports have suggested that severe generalized disease may show some decreased
antibody levels (Califano et al., 1999, Wang et al., 2005, Takeuchi et al., 2006, Hwang et al.,
2014). Treatment of periodontal disease is typically associated with early increases, but
longer-term decreases with successful therapy in antibody specific for oral bacteria
(Ebersole et al., 1985, Mooney et al., 1995, Beikler et al., 1999, Sakai et al., 2001, Yamazaki
et al., 2004). While many of these biomolecules have been detected in saliva and correlate
with periodontal disease, a wide array of them have also been detected in serum associated
with chronic inflammation related to the oral disease (Fain, 2006, Zakynthinos and Pappa,
2009, Cierny et al., 2014, Wu et al., 2010). Nevertheless, a clinical history needs to be a
portion of the patient characterization to minimize false-positive responses in periodontally
healthy subjects.

Author Manuscript

Consequently, the use of a panel of potential biomarkers, whether in serum, gingival
crevicular fluid, or saliva could help dentistry move towards the era of precision medicine
(Flores et al., 2013, Schmidt, 2014, Cesario et al., 2014). This concept is consistent with the
programmatic emphasis of the National Institute for Dental and Craniofacial Research
described as “Ongoing analyses of … information in many fields of biomedicine are
uncovering new approaches for diagnosing and managing disease based on molecular
signatures, rather than relying mainly on symptoms and clinical assessment”. One of the
objectives of this initiative is to discern distinct disease groups from an integrated panel of
J Clin Periodontol. Author manuscript; available in PMC 2018 March 01.
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biomarkers across multiple scales using sophisticated biomedical informatics approaches
while providing insights into patient-specific variations, as well as potential interactions
between these biomarkers. Classical approaches using traditional single classifier systems
have been useful but often investigate differences between the disease groups at a single
scale (e.g. molecular expression profiling). Single classifier systems also use all the
biomarkers simultaneously in classification process and do not provide insights into
potential cross-talk between these biomarkers. The dimensionality of feature space of single
classifier systems using all features is often comparable to the sample size affecting their
overall performance and generalizability. Ensemble classification approaches such as SVA
used in the present study overcomes these limitations by projecting the samples in a twodimensional space. More importantly, SVA is shown to reveal potential cross-talk and
interactions between the biomarkers across multiple scales as well as variations within the
disease groups. These interactions are modeled as weighted undirected graphs from the
ensemble sets returned by SVA. Also of interest was targeting a group of smokers, since
there is conclusive evidence for the negative impact of this environmental challenge on the
expression, severity, altered therapeutic response, and response to regenerative procedures
(Reynolds, 2014, Michalowicz et al., 2014, Johannsen et al., 2014, Eke et al., 2016). Of
critical consequence in developing these biologic models is to discern how they can be
utilized to improve professional clinical decisions and patient care. We believe that this
transformation will need to occur in at least three steps. First, to delineate the appropriate
panel of biomarkers in specific diagnostic fluids; second, develop improved methods for
more rapid assessment of actionable biomarker profiles; and, finally, to implement these 21st
century approaches towards modifying the current clinical and insurance based decision
paradigm for a procedure-based doctrine of treating existing disease versus a preemptive,
preventive approach to this oral infection and disease.

Author Manuscript
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The results presented demonstrate the sensitivity of SVA to be considerably higher than that
of traditional single classifier systems. Proclivity estimates from SVA also revealed
considerable variation within the periodontitis group. Ensemble sets of three representative
periodontitis test samples and their proclivities and patient-specific networks were
investigated. The patient-specific network abstraction of the borderline sample with equal
proclivity to non-periodontitis and periodontitis was markedly different from the other two
samples. Based on these results, the responses to the oral bacteria, reflecting the oral
colonization/infection challenge to the host of both pathogens and commensal bacteria were
highly informative in creating the profiles delineating the periodontitis patients. Thus, this
adaptive immune response, which appears to be underappreciated within the context of the
recent emphasis on innate immune and inflammatory response cells and molecules, needs to
be re-examined in more detail as a fundamental interactive component that differentiates
destructive periodontitis from health. These types of findings are generally consistent with
existing microbiome data (Shchipkova et al., 2010, Bizzarro et al., 2013, Camelo-Castillo et
al., 2015) and individual analyte host response data (Barbour et al., 1997, Apatzidou et al.,
2005, Al-Ghamdi and Anil, 2007, Hayman et al., 2011, Lutfioglu et al., 2016) supporting
differences in colonization and local and systemic reactivity of smokers compared to
nonsmokers. As importantly, the subset of periodontitis patients that were determined to
present distinct profiles, including non-standard and unlinked responses, will be of particular
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interest relative to the details of their disease and treatment response experiences. This
concept also incorporates an important limitation of this cross-sectional study design. Some
of the greatest value of modeling disease initiation and progression would be for the
biomarker complex to be capable of predicting the disease process in an individual patients.
Thus, this innovative approach to evaluating the biomarker profiles will require a prospective
longitudinal study design to address this important gap in the field.
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Clinical Relevance
Scientific rationale for the study: Various studies have suggested a relationship between
Scientific rationale for the study
Varied inflammatory and immune responses to the oral microbiomes lead to considerable
heterogeneity in smokers with periodontitis. Understanding patient-specific variation
using an array of biomarkers can assist in developing patient-tailored interventions.
Principal findings

Author Manuscript

The results identified a subset of smokers with periodontitis with markedly different host
response profiles. Patient-specific network abstractions also revealed the interplay
between the various biomarkers across multiple scales including oral microbiome and
their critical role in discerning smokers with periodontitis and non-periodontitis.
Practical implications
Biomarkers of the oral microbiome can be useful in discerning biological underpinnings
of periodontitis and non-periodontitis in smokers, as well as revealing potential variations
within this periodontitis population
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Working principle of traditional single classifier system C using salivary (S1, S2) and
microbial (M1, M2) biomarkers simultaneously as features in the classification process is
shown in (a) whereas those of SVA using pairs of biomarkers as features and an ensemble of
classifiers {C12,C13,C14,C23,C24,C34} is shown in (b). Imposing the optimal sensitivity
threshold in SVA returns a subset of classifiers {C12,C13,C14,C23}. The training samples
(TR1,TR2,TR3,TR4) were used to learn the classifiers and used subsequently to predict the
labels of the test samples (TS1,TS2). The normalized vote-counts of the periodontitis test
, indicating
samples TS1 and TS2 using majority voting is identical
equal proclivity of TS1 and TS2 to periodontitis group. However, network abstractions of
their ensemble sets exhibit markedly different topologies revealing patient-specific
variations within the periodontitis subjects and cross-talk between the salivary and microbial
biomarkers.
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Figure 2.

Performance measures sensitivity (solid line), specificity (dotted line) and accuracy (dashed
line) estimated on the training sample as a function of the sensitivity threshold δ of the base
classifiers using SVA-SVM is shown. Each circle represents the average estimate over (N =
100) independent realizations.
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Figure 3.
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Average differential proclivity estimates of the periodontitis test samples (N = 17) is shown
on the left averaged over (N = 100) independent realizations. Three representative samples
(6, 14, 9) with varying differential proclivities are shown in dark circles (left). Dashed line
represents samples with equal proclivity to periodontitis and non-periodontitis groups with
dark and white arrows representing increasing proclivity to periodontitis and nonperiodontitis groups. Samples 6 and 14 have similar differential proclivities (Δ ~ 0.75) in
contrast to that of the borderline sample 9 (Δ ~ 0).
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Patient-specific networks for representative periodontitis test samples (6, 14) shown in (a, b)
had markedly different topology from that of sample 9 (c). For clarity, variables
corresponding to (i) pathogenic bacteria Aggregatibacter actinomycetemcomitans (Aa),
Porphyromonas gingivalis (Pg), Treponema denticola (Td), (ii) commensal bacteria
Streptococcus sanguinis (Ss), Actinomyces naeslundii (An), Veillonella parvula (Vp),
Capnocytophaga ochracea (Co), (iii) molecular markers interleukin 1β (IL1b), prostaglandin
E2 (PGE2), plasminogen activator inhibitor-1 (PAI-1), myeloperoxidase (MPO) and (iv)
other markers corresponding to years of smoking (Yrs), salivary cotinine level (Cot) and age
(Age) are shown in yellow, green, cyan and gray colors in (a, b, c) respectively. Each edge
corresponds to a classifier with its thickness proportional to the classifier confidence in each
of the subplots. For clarity, only edges corresponding to classifiers whose confidence > 40%
is shown in (a, b, c). In (a) and (b) the top four highly connected nodes (Aa, PGE2, An, Td)
are shown in the outer circle.
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Performance of traditional single classifiers and SVA-SVM on an independent validation cohort
Classification Technique

Sensitivity

Specificity

Accuracy

LDA

0.50 ± 0.13

0.67 ± 0.13

0.58 ± 0.08

QDA

0.51 ± 0.10

0.56 ± 0.11

0.54 ± 0.07

Naïve Bayes

0.32 ± 0.06

0.70 ± 0.09

0.51 ± 0.05

CART

0.59 ± 0.18

0.53 ± 0.17

0.56 ± 0.10

SVM

0.60 ± 0.15

0.56 ± 0.15

0.58 ± 0.09

Traditional Single Classifiers

Selective Voting Ensemble Classification Approach
SVA-SVM with δ = 0.5

0.70 ± 0.07

0.45 ± 0.03

0.58 ± 0.04

SVA-SVM with δ = 0.8

0.85 ± 0.08

0.27 ± 0.09

0.56 ± 0.05
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